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712 JOURNAABSTRACT: We examined uptake of the model therapeutic agent, minoxidil, into
appendages, stratum corneum (SC), and through human skin, under the influence of
different vehicles. Quantitative estimation of therapeutic drug deposition into all three
areas has not previously been reported. Finite doses of minoxidil (2%, w/v) in formula-
tions containing varying amounts of ethanol, propylene glycol (PG), and water (60:20:20,
80:20:0, and 0:80:20 by volume, respectively) were used. Minoxidil in SC (by tape
stripping), appendages (by cyanoacrylate casting), and receptor fluid was determined
by liquid scintillation counting. At early times (30 min, 2 h), ethanol-containing for-
mulations (60:20:20 and 80:20:0) caused significantly greater minoxidil retention in SC
and appendages, compared to the formulation lacking ethanol (0:80:20). A significant
increase in minoxidil receptor penetration occurred with the PG-rich 0:80:20 formula-
tion after 12 h. We showed that deposition of minoxidil into appendages, SC, and skin
penetration into receptor fluid were similar in magnitude. Transport by the appendageal
route is likely to be a key determinant of hair growth promotion by minoxidil.  2009
Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 99:712–718, 2010Keywords: absorption; formulation vehicle; membrane transport; passive diffusion;
skin; transdermal drug deliveryINTRODUCTION
The differential targeting of topically applied com-
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L OF PHARMACEUTICAL SCIENCES, VOL. 99, NO. 2, FEBUAthere have been a number of studies examining
appendageal deposition, particularly of nanopar-
ticles,1 and other work aiming to determine the
contribution of appendageal transport to skin
penetration,2 to our knowledge there are no
reports examining the deposition of therapeutic
compounds to all three areas. The aim of this work
was to study uptake, through a quantitative esti-
mate of deposition of the model therapeutic agent,
minoxidil, into appendages, SC, and through
human skin, under the influence of different
vehicles.
There is increasing recognition of the contribu-
tions to transdermal delivery made by ‘‘shuntRY 2010
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cularly at early times.4 This contribution has been
evaluated, with varying degrees of acceptance, by
indirect methods, for example, by a comparison
between areas of different follicular density5 or
between intact and scarred skin,6 by physical
blocking of follicular openings,7 or by the use of
the in vitro skin sandwich technique.8 In addition,
rather than regarding follicles as shunts for trans-
dermal delivery, some attention has been given to
direct targeting of hair follicles by therapeutic
agents, such as for acne and alopecia. To this end,
attempts have been made to quantitate material
retained in follicles after topical application of
model penetrants such as dyes9 and nanoparti-
cles,1 but little has been done with therapeutic
compounds and the area remains difficult and
incompletely validated.10 A useful approach is
that of differential stripping.11 Introduced by
Marks and Dawber,12 this technique allows
quantitation of SC retention by tape stripping
and of follicular retention by cyanoacrylate
casting.1
The targeting of topically applied substances
to particular skin sites can be approached by
manipulating the components of the formulation.
In this work, we chose to prepare formulations
with different proportions of three common
vehicles, ethanol, propylene glycol (PG), and
water. Ethanol and PG rapidly diffuse into
the SC13 and may act as penetration enhancers
by a variety of mechanisms.13–15 Of interest here
are the effects on membrane properties to alter
drug permeation, following alcohol diffusion into
the membrane. As well, ethanol could potentially
extract or solubilize sebum to promote follicular
delivery in some cases. The use of water in
formulations aids skin hydration, thus enhancing
transdermal delivery of many drugs. This may be
particularly important when vehicles which tend
to desiccate the skin are present, such as ethanol
and PG.
While the mechanism of action of the model
compound, minoxidil remains unclear, the hair
follicle has been regarded as the site of action16
and a recent report identified K(ATP) channels
responsive to minoxidil located in human follicu-
lar dermal papillae.17 The uptake of minoxidil was
studied by measuring penetration into the recep-
tor of Franz diffusion cells and by differential
stripping, consisting of tape stripping (20 times) to
sample SC content, which reflects partitioning of
minoxidil into the skin barrier layer and cyanoa-
crylate casting to sample minoxidil depositedDOI 10.1002/jps JOURwithin the follicle. Three prototype formulations
with differing ethanol, PG, and water content
were chosen; in proportion by volume of 60:20:20,
80:20:0 (no water) and 0:80:20 (no ethanol),
respectively. Finite doses of 2% minoxidil (5mL/
cm2) were applied to excised full thickness human
skin. This dose is similar to that applied to the
human scalp under ‘‘in use’’ conditions (3–5mL/
cm2). The results were interpreted in terms of
solvent evaporation and individual vehicle effects.EXPERIMENTAL
Chemicals
3H-minoxidil (Minoxidil, [piperyl-3,4-3H], ART-
0711-250mCi) was purchased from American
Radiolabeled Chemicals, Inc. (St. Louis, MO).
Minoxidil was supplied by the Therapeutics
Research Unit. Ethanol and PG were purchased
from Sigma–Aldrich Pty. Ltd. (Sydney, Australia).
The scintillation cocktail used was Emulsifier-
Safe (PerkinElmer Pty Ltd, Melbourne, Austra-
lia). For cyanoacrylate casting, we used ‘‘Quick
Fix Supa Glue’’ (Selleys Pty Ltd, Padstow,
Australia). Formulations containing 2% (g/mL)
minoxidil and a trace amount of 3H-minoxidil
(approx. 1mCi/7mL) were prepared in three
different vehicle mixtures. These contained (by
volume) 60% ethanol, 20% PG, and 20% water
(formulation 1); 80% ethanol and 20% PG
(formulation 2); and 80% PG and 20% water
(formulation 3). In the following, these formula-
tions will be designated 60:20:20, 80:20:0, and
0:80:20, respectively.
Human Skin Membranes
Human abdominal skin was obtained from volun-
teers undergoing elective surgery. The collection
of skin was approved by the Princess Alexandra
Hospital Research Committee (Approval no. 097/
090, administered by the University of Queens-
land Human Ethics Committee) and donors gave
informed written consent. Full thickness skin,
which was used in the majority of experiments,
was separated from underlying fat and epidermal
and dermal membranes were prepared from full
thickness skin by floating the skin in water at
608C for 1 min and peeling off the epidermal layer.
Both full thickness skin and epidermal mem-
branes were stored frozen at 208C until use.NAL OF PHARMACEUTICAL SCIENCES, VOL. 99, NO. 2, FEBUARY 2010
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The experiments were performed using full
thickness skin as described above, from three
different donors (five replicates per skin) in glass
horizontal static Franz-type diffusion cells, using
phosphate buffered saline, pH 7.4 (PBS) as the
receptor phase. The exposed skin surface area was
1.33 cm2 in all cases. The diffusion cells were
placed in a water bath, to maintain the receptor
phase temperature at 358C, over a magnetic
15 point stirring plate. Magnetic stirrer bars in
the bottom of each receptor chamber maintained
mixing of the receptor fluid. The prepared Franz
cells remained in the water bath for a minimum of
30 min before dosing, to ensure the skin was
adequately hydrated. After hydration, resistance
across the skin was measured with a standard
multimeter, with PBS in the donor and receptor
chambers. A resistance reading of 20 kV indi-
cated acceptable skin integrity. If resistance was
<20 kV, skin was replaced in that cell. The donor
and receptor chambers were then emptied, the
receptor chamber was refilled with fresh PBS and
the cells equilibrated in the water bath for a
further 15 min before dosing.
Finite doses of the above formulations were
applied to the skin at the rate of 5mL/cm2 (i.e.,
7mL in all cases, for a 1.33 cm2 membrane area),
using an M10 Gilson positive displacement
pipette. The 7mL applications were spread evenly
over the skin surface with the rubber tip of a 1 mL
syringe plunger, using a gentle horizontal motion
to prevent damage to the skin surface and the
amount of radioactive material remaining on the
rubber tip was quantitated, in order to ascertain
the actual dose applied.
At appropriate times up to 28 h, 200mL
samples were removed from the sampling arm
of the diffusion cell using extra long pipette tips,
with this volume being replaced with fresh
receptor solution after each sample to maintain
the receptor chamber volume.
Differential Stripping Studies
Separate Franz diffusion studies were carried out
for 30 min, 2 h and 5 h as above, with skin from one
donor and four replicates. After the designated
time, the cells were dismantled and the skin was
swabbed three times with an ethanol moistened
cotton buds. These swab samples were saved
separately for radioactivity quantitation. After
10 min air drying, the skin was subjected to tape
stripping, which involves even application ofJOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 99, NO. 2, FEBUARY 2010adhesive tape to the exposed skin surface and
careful removal, up to a maximum of 20 times.
Individual tapes were placed into separate scin-
tillation vials and soaked overnight with 2 mL
scintillation fluid (Emulsifier-Safe) before vortex-
ing and quantitation by liquid scintillation
counting (LSC). The total amount of minoxidil
deposited within the SC was obtained by summa-
tion of the amounts measured on the individual
tapes. Results for the first two tapes were not
included, as this represents unabsorbed surface
material only.
Following tape stripping, follicular casts were
prepared. One drop of superglue was placed on a
glass microscope slide, which was then pressed
onto the surface of the stripped skin and held in
place under light pressure. After 15 min, when the
glue had hardened, the slide was peeled carefully
from the skin, taking the contents of the skin
appendages with it. The superglue was dissolved
by rubbing with acetone-soaked cotton buds (4)
and the individual cotton buds containing the
sampled follicular contents were soaked overnight
in 2 mL scintillation fluid before vortexing and
quantitation by LSC. The processes of thorough
swabbing and tape stripping of the skin ensured
that all surface material was removed prior to
cyanoacrylate casting, so that material recovered
with the casts represented appendageal content.Data Analysis
Skin penetration was assessed by the comparison
of cumulative amount versus time profiles. Where
appropriate, statistical differences were deter-
mined by the General Linear Model (multivari-
ate), with post hoc comparisons by Tukey’s test
(SPSS ver. 14.0).RESULTS
Uptake of Minoxidil Into Follicles and
Stratum Corneum
The recovery of minoxidil from cyanoacrylate
casts is shown in Figure 1A. Significantly more
minoxidil was recovered from the appendages
after application of formulations containing etha-
nol (60:20:20 and 80:20:0) than the formulation
lacking ethanol (0:80:20), particularly at early
times of 30 min–2 h following application. The
presence of water in the ethanol-containing
formulations also appeared to lead to greaterDOI 10.1002/jps
Figure 1. Minoxidil content of (A) follicular casts and
(B) tape strips 3–20, taken from full thickness human
skin after 30 min, 2 h, and 5 h exposure to minoxidil-
containing formulations applied at a dose of 5mL/cm2
(meanSE, n¼ 4 for each formulation). Formulations
contained ethanol, propylene glycol, and water in
volume ratios of 60:20:20 (open bars), 80:20:0 (cross-
hatched bars), and 0:80:20 (filled bars). Significant
differences (p< 0.05) between pairs of mean values
are indicated by asterisks.
Figure 2. Mean (SE) cumulative minoxidil pene-
tration versus time following application of 2% minox-
idil formulations (5mL/cm2). Formulations contained
ethanol, propylene glycol, and water in volume ratios
of 60:20:20 (closed circles), 80:20:0 (open triangles),
and 0:80:20 (open circles). Data from three different
human full thickness skins and five cells per skin were
combined.
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seen in the comparison of 60:20:20 and 80:20:0
in Figure 1A, although the difference between
these formulations failed to reach statistical
significance.
The effect of the different formulations on
minoxidil penetration into the SC and the
subsequent diffusion concentrations established
within the membrane, assessed by tape stripping,
is illustrated in Figure 1B. Application of the
60:20:20 and 80:20:0 formulations (containing
ethanol), resulted in significantly more minoxidil
being recovered from the SC than the 0:80:20DOI 10.1002/jps JOURformulation (containing no ethanol). In contrast
to results from cyanoacrylate casts, recovery from
SC was not enhanced by the presence of water in
the ethanol-containing formulations.
Penetration Profile up to 28 h
The relative cumulative amounts of minoxidil
penetrating human full thickness skin from each
of the three test formulations are shown in
Figure 2. As shown by the slopes of the penetra-
tion versus time curves, minoxidil flux in the first
12 h was in the order 60:20:20> 80:20:0> 0:80:20.
The highest flux was seen with the vehicle
containing ethanol and water and the lowest flux
was seen with the vehicle containing no ethanol.
A dramatic change occurred in the subsequent
12 h, with an accelerated flux seen with the
0:80:20 vehicle.
The amount of minoxidil retained in the skin at
the end of the study (representing material that
had passed through the SC barrier) was in the
order 0:80:20> 60:20:20> 80:20:0, the same as
observed for recovery of minoxidil from the
receptor chamber. However, the amount of
minoxidil retained in the SC, represented by
recovery from the tape strips, showed a different
pattern (60:20:20> 0:80:20> 80:20:0), supporting
the notion that the 0:80:20 formulation allowed
minoxidil to more readily traverse the SC barrier
at longer times.NAL OF PHARMACEUTICAL SCIENCES, VOL. 99, NO. 2, FEBUARY 2010
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Although it was previously thought that the
appendageal route was relatively unimportant,
as the area of skin containing these appendages
is probably <0.1% of the total skin area,4,18 we
showed in this study that minoxidil recovery from
appendages and SC was of the same order as the
cumulative minoxidil penetration through the
skin. In addition, we showed that the amount of
minoxidil recovered from the appendages and SC
after 30 min and 2 h exposure was dependent on
the vehicle composition of the applied minoxidil
formulation. The presence of ethanol and possibly
water in the formulation promoted accumulation
of minoxidil in these areas.
We also observed differences in the cumulative
amount of minoxidil measured in the receptor
fluid. At earlier times (before about 12 h expo-
sure), the effect of formulation was similar to that
seen on appendageal and SC recovery (i.e., the
ethanol-containing formulations were favored).
A change occurred after 12 h, with a marked
increase in flux seen with the formulation con-
taining the greatest proportion of PG but no
ethanol. These results may provide important
mechanistic insights.Effects at Early Times
Minoxidil was applied in three different vehicle
mixtures, two of which contained ethanol and one
which did not. We showed significantly greater
amounts of minoxidil recovered from SC (by tape
stripping) and from appendages (by cyanoacrylate
casts) after penetration from ethanol-containing
formulations (60:20:20 and 80:20:0), compared to
the formulation lacking ethanol (0:80:20). This
was particularly apparent at early times (30 min
and 2 h). Similar effects by ethanol have been seen
in previous studies. Tata et al.19 showed increas-
ing recovery of minoxidil from hairless mouse
epidermis and dermis with increasing ethanol
in the vehicle, while Grams and Bouwstra9
found that follicular penetration of low lipophili-
city fluorescent dyes was increased by addition
of ethanol to the vehicle. The same ethanol-
containing formulations caused greater cumula-
tive receptor penetration for the first 12 h of
application. Early minoxidil uptake favoring
ethanol-containing formulations probably reflects
the partitioning of ethanol (in which minoxidil
is approximately six times more soluble than inJOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 99, NO. 2, FEBUARY 2010water) rapidly into lipid-rich skin compartments
(including follicles), carrying minoxidil with it.
Such a ‘‘pull effect’’ mechanism has been invoked
to explain the enhancement of skin penetration of
mefenamic acid by ethanol.20
In considering the effects at earlier times, it
became clear that evaporation of the more volatile
components, ethanol and water, was important.
We hypothesized that the follicle, SC, and receptor
minoxidil content resulting from application of a
particular formulation would be determined by
the minoxidil concentration remaining on the skin
after evaporation of the volatile solvents, ethanol,
and water. An ethanol/PG/water mixture contain-
ing minoxidil would pass through a range of
evaporation stages; viz. (i) ethanol and water
evaporating but still present, (ii) ethanol and
water completely evaporated but PG largely
undepleted, (iii) PG evaporating, to finally leave
any remaining minoxidil deposited on the skin
surface. Previous investigations of these solvent
mixtures found that after about 2 h, ethanol and
water had completely evaporated, while most of
the PG remained.21 In the formulations studied
here, the minoxidil concentration would therefore
increase in proportion to the decrease in volume
caused by evaporation.
After about 2 h, in 60:20:20 or 80:20:0 mixtures
of ethanol/PG/water, the minoxidil concentration
would increase fivefold from 2% to 10% after
evaporation of ethanol and water, but in a 0:80:20
mixture it would rise from 2% to only 2.5%. At the
358C temperatures at which the experiment was
conducted, minoxidil would be expected to remain
in solution at 10%, without reaching supersatura-
tion. As the flux of solute transport is a function of
thermodynamic activity, which in turn is propor-
tional to solute concentration in the vehicle, we
would therefore expect that at this point, the
instantaneous minoxidil flux for the 60:20:20 and
80:20:0 mixtures would be four times that seen
with 0:80:20. This would be reflected in the
amount of minoxidil recovered from receptor,
skin, and appendages. At 5 h, with only PG
expected to remain, cast and tape amounts for
the 60:20:20 and 80:20:0 mixtures were four times
those seen with the 0:80:20 mixture, as predicted.Penetration Profile Over Longer Time (28 h)
An apparent abrupt change in penetration flux
occurred for the 0:80:20 formulation only, at
12 h. Significantly, these observations were seenDOI 10.1002/jps
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samples used in the experiments. This suggests
a clear change in mechanism of transport over
time. In the initial 12 h, maximum penetration
was obtained with the formulations containing
ethanol and the least PG, indicating that PG is
thermodynamically unfavourable for penetration.
Importantly, for the two formulations with the
same water content (60:20:20 and 0:80:20), the
ratio of amount penetrated (4.7) was close to that
of 4, which would have been predicted on the basis
of the concentration of minoxidil remaining in the
residue PG on the skin (5.6mL for 0:80:20, 1.4mL
for 60:20:20).
By contrast, after the initial 12 h, maximum
penetration was soon obtained by the formulation
with the most PG. We interpret this as a change in
transport mechanism brought about by a physical
change in the membrane (SC) induced by PG.
Recognizing that SC uptake represents mainly a
partition process whereas skin penetration reflects
both partition and diffusion, this may be due to the
slow uptake of PG into the membrane and its
gradual alteration of SC permeability. Interest-
ingly, Tata et al.19 saw a similar enhancement of
minoxidil uptake into hairless mouse epidermis
after 12 h with PG-rich vehicles. The relatively
poor SC minoxidil uptake from the 80:20:0
formulation may reflect the low permeability of
the dehydrated membrane in this water-free
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